Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002020.pdf 0001562180-24-002020.rtf 0001562180-24-002020.xls View HTML
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002021.pdf 0001562180-24-002021.rtf 0001562180-24-002021.xls View HTML
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002023.pdf 0001562180-24-002023.rtf 0001562180-24-002023.xls View HTML
May 9, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-003948.pdf 0001562180-24-003948.rtf 0001562180-24-003948.xls View HTML
May 14, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004025.pdf 0001562180-24-004025.rtf 0001562180-24-004025.xls View HTML
May 14, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004026.pdf 0001562180-24-004026.rtf 0001562180-24-004026.xls View HTML
April 24, 2020	UPLOAD	UPLOAD	View HTML
February 14, 2017	UPLOAD	UPLOAD	0000000000-17-005267.pdf View HTML
October 26, 2018	UPLOAD	UPLOAD	0000000000-18-033597.pdf 0000000000-18-033597.rtf View HTML
October 18, 2018	UPLOAD	UPLOAD	0000000000-18-032657.pdf 0000000000-18-032657.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax